Philadelphia, United States
UE LifeSciences is a fast-growing med-tech company founded in 2009. With the slogan "Making the hope of early detection, a reality," the company is dedicated to bringing the promise of early cancer detection to women worldwide. Its flagship products, iBreastExam and cervAIcal, have reached over 250,000 women in 12 countries, demonstrating the company's global impact. UE LifeSciences has experienced significant growth, with a revenue increase of five-fold in the past three years and distribution channels established in 10 countries and counting.
The company has received substantial recognition, having secured over $6 million in grants, international awards and equity capital. Notably, on 23 November 2021, UE LifeSciences successfully secured a $480.31K Seed Round investment. The company's work has gained widespread acclaim, with features on platforms such as TED Talks and coverage in prominent publications including The New York Times, BBC World News, Forbes, and others.
UE LifeSciences' impactful presence in the med-tech industry, proven global reach, and successful fundraising efforts make it an attractive prospect for potential venture capital investors seeking opportunities in the healthcare and technology sectors.
